Physician

Manubhai S Patel, M.D.

According to 2025 Medicare claims, Manubhai Patel, M.D. (NPI: 1487659850) practices hematology/oncology in the Jackson, MS market, with the plurality of this provider's patient population coming from Rankin, MS. This provider's primary affiliated billing organization is JACKSON ONCOLOGY ASSOCIATES (NPI: 1295776136; TIN: 640619700) and primary practice location at 39216-4121. Patel is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645) and Ochsner Senior Care Network, LLC (ACO ID: A5662), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 877 traditional Medicare patients, billed 215,899 HCPCS/CPT codes, and received $3,879,535 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,576 prescription claims across 273 beneficiaries totaling $4,055,836 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 46 claims. Open Payments data shows 58 records totaling $1,301. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,603,991 to $3,879,535. Similarly, Part D prescription costs have risen steadily, from $1,540,152 to $4,055,836. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,757 and ending at $359.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	718	103,355	$1,603,991
2016	697	143,312	$1,948,125
2017	744	201,489	$2,297,152
2018	861	193,153	$3,065,873
2019	826	265,252	$3,225,302
2020	713	220,479	$3,517,567
2021	745	245,160	$2,821,934
2022	722	259,086	$3,239,716
2023	760	211,169	$2,946,746
2024	877	215,899	$3,879,535

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	295	2,274	$1,540,152
2016	305	2,386	$2,279,373
2017	329	2,538	$2,601,915
2018	334	2,526	$2,881,772
2019	311	2,023	$2,952,416
2020	252	1,752	$3,860,848
2021	238	1,518	$4,181,476
2022	212	1,345	$4,115,299
2023	218	1,185	$2,735,216
2024	273	1,576	$4,055,836

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	141	$87,651
2016	40	154	$64,939
2017	N/R	70	$20,571
2018	N/R	121	$19,969
2019	N/R	125	$11,782
2020	N/R	138	$9,323
2021	N/R	11	$1,301
2022	N/R	11	$402
2023	N/R	33	$6,230
2024	N/R	46	$1,109

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	530	1,277	$89
82728	Ferritin (blood protein) level	222	344	$13
80053	Blood test, comprehensive group of blood chemicals	409	1,294	$10
36415	Insertion of needle into vein for collection of blood sample	427	1,320	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	447	1,538	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	81	2,156	$785,973
Calquence	Acalabrutinib Maleate	44	1,320	$554,122
Revlimid	Lenalidomide	31	735	$358,529
Jakafi	Ruxolitinib Phosphate	17	510	$302,763
Xtandi	Enzalutamide	17	510	$258,627

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	18	$651
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	17	$320
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	11	$138

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	58	$1,301	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Manubhai S. Patel, M.D.?

Tedicare shows public-source Medicare data for Manubhai S. Patel, M.D. (NPI 1487659850), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Manubhai S. Patel, M.D. have ACO affiliation data?

Manubhai S. Patel, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645) and Ochsner Senior Care Network, LLC (MSSP, ACO ID A5662).

What billing organization is linked to Manubhai S. Patel, M.D.?

Manubhai S. Patel, M.D. is linked to JACKSON ONCOLOGY ASSOCIATES (billing NPI 1295776136) in the available physician profile data.

Does Manubhai S. Patel, M.D. have Open Payments data?

Manubhai S. Patel, M.D. has 58 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.